August 29, 2014 8:37 PM ET


Company Overview of Replicon Technologies, Inc.

Company Overview

Replicon Technologies, Inc. operates as a developer of replicons (RNA molecules that have the capacity for self-replication) and a patented procedure to encapsulate them into virus-like particles for the large-scale growth and purification required for therapeutic applications. Replicon Technologies, Inc. was founded in 1997 and is based in Birmingham, Alabama.

2800 Milan Court

Suite 282

Birmingham, AL 35211-6973

United States

Founded in 1997





Key Executives for Replicon Technologies, Inc.

Replicon Technologies, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
CG Therapeutics, Inc. United States
Zimmer Orthobiologics, Inc. United States
AuraZyme Pharmaceuticals, Inc. United States
ZaBeCor Pharmaceuticals, LLC United States
Strategic Science & Technologies, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Replicon Technologies, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at